Dichloroacetate Treatment of Congenital Lactic Acidosis Phase B: Expanded Access
NO_LONGER_AVAILABLE
Conditions studied: Mitochondrial Enzyme Deficiencies
In brief
Expanded access to DCA as continued treatment for congenital lactic acidosis.
Key facts
- Study ID
- NCT01797276
- Run by
- University of Florida
- Last updated by the study team
- 2017-08-08
Who can join
Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of congenital lactic acidosis
- Participation in Study: #183-1992: Dichloroacetate Treatment of Congenital Lactic Acidosis Exclusion Criteria:
- Intolerance to DCA
Where it is running
- University of Florida Box 100226 — Gainesville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.